tradmap

SLN Earnings Silence Therapeutics Plc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$0 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $22M $43M 2022 2023 2024 2025
Revenue
Net income (annual)
-$89M -$44M $0 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $13M $25M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$36M -$12M $12M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–12 of 12
Q2 20262026-06-30-0.192026-08-1010-Q
Q1 20262026-03-31-0.112026-05-0710-Q
FY 20252025-12-31-0.632026-03-0510-K
Q3 20252025-09-30-0.542025-11-0610-Q
Q2 20262025-06-30-0.392026-08-1010-Q
Q1 20262025-03-31-0.202026-05-0710-Q
FY 20252024-12-31-0.332026-03-0510-K
Q3 20252024-09-30-0.422025-11-0610-Q
Q2 20252024-06-30-0.162025-08-0710-Q
Q1 20252024-03-31-0.022025-05-0810-Q
FY 20242023-12-31-0.492025-02-2710-K
FY 20242022-12-31-0.522025-02-2710-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.